RefleXion to incorporate Limbus software into radiotherapy planning system
Summary
RefleXion Medical has signed a licensing agreement with Limbus AI to incorporate the latter’s contouring software into its radiotherapy treatment planning system. The manual contouring of tumours and organs at risk (OARs) in radiotherapy planning is a time-intensive task with variability in clinician output. RefleXion co-founder and chief technology officer Sam Mazin said: “Contouring is one of the most time-consuming tasks in radiotherapy planning, and often contributes to treatment delays. Depending on the complexity of the treatment plan, we expect contouring time reductions of up to 80%, thus ensuring that patients receive timely treatment.” Featuring SCINTIX technology, the RefleXion X1 dual-treatment modality radiotherapy platform is capable of treating patients with various stages of solid tumours. “This should enhance precision in distinguishing adjacent structures and yield consistent, reliable contouring results, ensuring patients receive the highest quality care possible.” In 2022, RefleXion signed licensing agreement with Mirada Medical to advance personalised cancer treatment.